Lithium Orotate 2.5; 60 vegetarian capsules, Dietary Supplement
Recalling firm: GMP Laboratories of America Inc
Downstream recall of a dietary supplement ingredient that was manufactured out of specifications.
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Feb 24, 2026.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
2.5mg Lot #: 21822 Expire date: 09/2026 10mg Lot#: 21108; 22649 Expire date: 10/2025; 01/2028
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Lithium Orotate 2.5; 60 vegetarian capsules, Dietary Supplement; Distributed by Mecene LLC. 447 Sutter St., Suite 405, San Fransisco, CA 94108 2.5 mg UPC#: X002T4OPLL 10 mg UPC#: X0031AXVE9
Original FDA recall reason
Downstream recall of a dietary supplement ingredient that was manufactured out of specifications.
Recall details
- Recall number
- H-0447-2025
- Event ID
- 97158
- FDA status
- Terminated
- Initiated
- Jun 24, 2025
- Reported
- Aug 20, 2025
- Classified
- Aug 8, 2025
- Terminated
- Feb 24, 2026
- Quantity
- ~185,482 capsules
- Location
- Anaheim, CA, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Telephone
Where it was distributed
Distribution was to a single customer who received product in California and Oklahoma.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.